August 2010 Research News
Prophylactic Surgery Reduces Risk for Women with Abnormal Breast Cancer Genes
August 31, 2010
Women with an abnormal breast cancer gene who had prophylactic surgery lowered their risk of both ovarian and breast cancer. Read more...
FDA Turns Down Accelerated Approval Request for T-DM1
August 27, 2010
The FDA has decided to not consider accelerated approval for T-DM1 to treat HER2-positive, advanced-stage breast cancer based on research results available as of August 2010. Read more...
Drinking Alcohol Increases Risk of Hormone-Receptor-Positive Breast Cancer
August 24, 2010
Regularly drinking alcohol increases the risk of lobular -- but not ductal -- hormone-receptor-positive breast cancer. Read more...
Hormone Replacement Therapy: Type and Time Used Linked to Increase in Risk
August 11, 2010
New research confirms that hormone replacement therapy increases the risk of hormone-receptor-positive breast cancer. Read more...
Number of White Girls Going Through Puberty at Younger Age Doubles
August 9, 2010
The number of white girls going through puberty at a younger age has doubled since the late 1990s, possibly increasing their future risk of breast cancer. Read more...
Can we help guide you?
Create a profile for better recommendations
-
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
-
Breast Self-Exam
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
-
Triple-Negative Breast Cancer
Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone...
